Thunderbird: Rapid Antibody Design using AI

This project will use artificial intelligence to fast-track the complex task of developing antibodies required for a vaccine and effective treatments for COVID-19.

Partner Co-investment - $0.8M

Supercluster Co-investment - $1.6M

Project Budget*- $2.4M

Project Partners

Project Overview

This project will use artificial intelligence to fast-track the complex task of developing antibodies required for a vaccine and effective treatments for COVID-19. Working with Zymeworks, a global leader in the design of antibodies, this artificial intelligence-powered platform will help identify new treatments with speed and effectiveness not previously available and through this,  accelerate our ability to protect Canadians against COVID-19 and other diseases.

*amounts at time of project selection

Get Involved

There are two ways that your organization can join the Supercluster and start to get involved in collaborative projects designed to build world class digital technologies while growing our ecosystem and capacity as we become a world leader in the digital transformation of our economies and our society.